Supernus Pharmaceuticals, Inc.
METHOD OF TREATMENT OF CNS DISORDERS
Last updated:
Abstract:
The invention comprises a method of treatment of CNS disorders by a pharmaceutical agent exhibiting combined noradrenergic, serotonergic or dopaminergic reuptake transporter inhibitory and .mu.-opioid agonistic activity.
Status:
Application
Type:
Utility
Filling date:
8 Nov 2019
Issue date:
5 Mar 2020